NCT05410080

Brief Summary

To determine and evaluate the diagnostic performance of Doppler sonography of umbilical artery (UA), fetal middle cereberal artery (MCA), ductus venosus (VD) and umbilical vein (UV) for prediction of adverse perinatal outcome among diabetic pregnant women.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 8, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

June 15, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2022

Completed
Last Updated

August 23, 2022

Status Verified

August 1, 2022

Enrollment Period

3 months

First QC Date

May 6, 2022

Last Update Submit

August 20, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • The diagnostic value of umbilical artery (UA) Doppler indices in predicting adverse perinatal outcome among diabetic pregnant patients

    The diagnostic value of umbilical artery (UA) Doppler indices (RI \& PI) in predicting adverse perinatal outcome among diabetic pregnant patients. Sensitivity and specificity of umbilical artery RI \& PI in detecting adverse perinatal outcome.

    within 24 hours before delivery

  • The diagnostic value of middle cerebral artery (MCA) Doppler indices in predicting adverse perinatal outcome among diabetic pregnant patients

    The diagnostic value of middle cerebral artery (MCA) Doppler indices (RI \& PI) in predicting adverse perinatal outcome among diabetic pregnant patients. Sensitivity and specificity of middle cerebral artery RI \& PI in detecting adverse perinatal outcome.

    within 24 hours before delivery

Secondary Outcomes (2)

  • The diagnostic value of cerebroplacental ratio (CPR) in predicting adverse perinatal outcome among diabetic pregnant patients.

    within 24 hours before delivery

  • The diagnostic value of ductus venosus Doppler indices in predicting adverse perinatal outcome among diabetic pregnant patients.

    within 24 hours before delivery

Study Arms (2)

good perinatal outcome

Fasting blood sugar 2 hours postprandial HBA1C Ultrasound and Doppler

Diagnostic Test: Fasting blood sugar, 2 hours postprandial, HBA1C ,Ultrasound and Doppler study

poor perinatal outcome

Fasting blood sugar 2 hours postprandial HBA1C Ultrasound and Doppler

Diagnostic Test: Fasting blood sugar, 2 hours postprandial, HBA1C ,Ultrasound and Doppler study

Interventions

Fasting blood sugar, 2 hours postprandial, HBA1C ,Ultrasound and Doppler study

good perinatal outcomepoor perinatal outcome

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant female
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

140 pregnant women, will be recruited from emergency and inpatients departments.

You may qualify if:

  • The included women age will range between 18 and 35 years old.
  • They will carry a singleton healthy living fetus at a gestational age between 34 and 39 weeks (confirmed by a reliable date for the last menstrual period or/and 1st trimester ultrasound scan).
  • known to be diabetic in the current pregnancy (PGDM or GDM).

You may not qualify if:

  • Women with other maternal medical disorders that may affect perinatal outcome rather than diabetes were excluded from the study.
  • women with pre-labour rupture of membrane.
  • antepartum hemorrhage, fetuses with congenital anomalies .
  • who will receive respiratory depressants (e.g., opioid analgesics) within 2 hours of delivery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cairo University

Cairo, 02, Egypt

RECRUITING

Kasr Alainy hospital (Faculty of Medicine-Cairo University)

Cairo, 11956, Egypt

RECRUITING

MeSH Terms

Conditions

Diabetes, GestationalFetal Macrosomia

Interventions

Postprandial PeriodEchocardiography, Doppler

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesFetal DiseasesPregnancy in DiabeticsCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDiabetes ComplicationsBirth WeightBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Digestive System Physiological PhenomenaDigestive System and Oral Physiological PhenomenaEchocardiographyCardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyUltrasonography, DopplerHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • Hany Saad, MD

    Kasr Alainy Hospital(Faculty of Medicine -Cairo university

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

May 6, 2022

First Posted

June 8, 2022

Study Start

June 15, 2022

Primary Completion

September 20, 2022

Study Completion

October 20, 2022

Last Updated

August 23, 2022

Record last verified: 2022-08

Locations